Initial Experience of Trans-radial Access for Hepatic Chemoembolization and Comparison to Trans-femoral Access

This abstract has open access
Abstract Summary
Abstract ID :
HAC694
Submission Type
Presentation Upload :
If the file does not load, click here to open/download the file.
Authors (including presenting author) :
TS Chan, LF Cheng, T Wong, HF Chan, NY Pan, WH Luk, KF Ma
Affiliation :
Department of Radiology, Princess Margaret Hospital
Introduction :
Trans-radial access has emerged as a valid alternative to the trans-femoral access for transcatheter arterial chemoembolization. Shorter monitoring time after the procedure, earlier ambulation, shorter hospital stay, and less discomfort associated with potentially reduced bleeding risks make trans-radial access an attractive alternative to trans-femoral access.
Objectives :
(1)To compare the fluoroscopy time of trans-radial approach and trans-femoral approach in patients undergoing hepatic chemoembolization, also in terms of (2) safety, (3) length of hospitalization and (4) patient satisfaction.
Methodology :
From September 2017, trans-radial access became another possible approach apart from the usual trans-femoral access for sub-diaphragmatic vascular interventions in our department. This study was a retrospective, single-center, intra-patient comparison of trans-femoral and trans-radial chemoembolization for patients with hepatic malignancies, who had underwent trans-femoral chemoembolization previously and then performed via trans-radial approach. This study included 14 consecutive patients and total 20 procedures were performed trans-radially. All procedures were performed by interventional radiologists (with at least 3 years of experience in interventional radiology). The primary outcome was the fluoroscopy time. The secondary outcomes included major complications, day of discharge after the procedure, patient’s preference on trans-radial access and trans-femoral access, and the reasons.
Result & Outcome :
The fluoroscopy time of trans-radial hepatic chemoembolization was not longer than trans-femoral approach (11.85±3.85 min VS 16.35±6.60 min, P =0.025 - derived from paired t-test and Wilcoxon signed-rank test). There were no major complications in trans-radial chemoembolization. Patients were discharged earlier with trans-radial access (1.58±1.61 VS 2.25±1.09, P =0.104), with some patients discharged on the same day after trans-radial hepatic chemoembolization. Trans-radial access was preferred by all the patients (14/14) for potential future trans-arterial procedures. The fluoroscopy time of trans-radial hepatic chemoembolization was not longer than trans-femoral approach. Trans-radial access is a safe alternative, with reduced length of hospitalization and improved patient satisfaction.

Associated Sessions

Similar Abstracts by Type

Abstract ID
Abstract Title
Abstract Topic
Submission Type
Primary Author
HAC720
Clinical Safety and Quality Service I
HA Staff
Maria SINN Dr
HAC456
Enhancing Partnership with Patients and Community
HA Staff
Donna TSE
HAC1262
Enhancing Partnership with Patients and Community
HA Staff
S F LEE Dr
HAC997
Clinical Safety and Quality Service II
HA Staff
K L CHAN